Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00714220 · ClinicalTrials.gov registry record

Quantitative Measurement of Nutritional Substrate Utilization in Patients With Amyotrophic Lateral Sclerosis (ALS)

A clinical trial, sponsored by Drexel University College of Medicine.

Terminated
Registry status
107
Enrollment target

NCT00714220 is a clinical trial that was terminated before completion, run by Drexel University College of Medicine. The registered enrollment target is 107 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00714220 was terminated before completion, sponsored by Drexel University College of Medicine.

TERMINATED
Registry status
107 participants
Enrollment target

Study Summary

The work of Nau et. al (Nau KL, Bromberg MB, Forshew DA, Katcha Vl. Individuals with amyotrophic lateral sclerosis are in caloric balance despite losses in mass. J Neurol Sci 1995;129 :47-49) showed that patients in the early stages of ALS initially increase their body fat. Another study showed that advanced ALS patients on mechanical ventilation were actually hypometabolic, supporting a hypothesis that ALS patients' daily oral intakes of calories fail to match their energy requirements, thus exacerbating their condition. This current study investigates and compares substrate utilization using a metabolic cart in controls and in ALS patients who are on and off ventilatory support to examine differences in substrate utilization between the two groups of ALS patients and the controls. (Substrate utilization is essentially the percentage of fats, carbohydrates, and protein utilized by the body.) The study will increase our understanding of the nutritional needs of ALS patients and improve our ability to provide the best possible nutrition in progressive illness.

Trial Details

FieldValue
Enrollment Target 107 participants
Start Date 2006-11
Est. Completion 2014-09

What the Registry Record Tells You About NCT00714220

The ClinicalTrials.gov registry entry for NCT00714220 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Drexel University College of Medicine, which has 25 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00714220 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00714220 about?

NCT00714220 is a clinical study titled "Quantitative Measurement of Nutritional Substrate Utilization in Patients With Amyotrophic Lateral Sclerosis (ALS)". The work of Nau et. al (Nau KL, Bromberg MB, Forshew DA, Katcha Vl. Individuals with amyotrophic lateral sclerosis are in caloric balance despite losses in mass. J Neurol Sci 1995;129 :47-49) showed that patients in the early stages of ALS initially increase their body fat. Another study showed that...

What is the current status of trial NCT00714220?

This trial is currently terminated. The enrollment target is 107 participants. The study started on 2006-11. Estimated completion is 2014-09.

Who is sponsoring clinical trial NCT00714220?

This trial is sponsored by Drexel University College of Medicine, which has 25 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.